Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.

David Ray, Shaolei Ren, Шломо МелмедJournal of Clinical Investigation 1996 · DOI

This 1996 study published in the Journal of Clinical Investigation explores the molecular bridge between the immune system and the endocrine stress response. Researchers demonstrate that Leukemia Inhibitory Factor (LIF)—a cytokine typically associated with immune signaling—is a potent regulator of the pituitary gland, acting through the STAT signaling pathway to drive the production of the stress hormone precursor, proopiomelanocortin (POMC).

Abstract

Leukemia inhibitory factor (LIF) and the related cytokine oncostatin M (OSM) were found to induce basal and corticotropin-releasing hormone (CRH)-induced POMC mRNA and ACTH secretion in AtT20 cells. LIF action is receptor-mediated, involving the activation of STAT1 and STAT3 signaling pathways. Notably, LIF potently synergizes with both CRH and cAMP induction of POMC transcription, suggesting a novel intrapituitary signaling mechanism that mediates the neuroimmune-pituitary interface.

The Problem: Mapping the Neuro-Immune Interface

The hypothalamic-pituitary-adrenal (HPA) axis is the body's central command for stress. Traditionally viewed as a top-down system, the hypothalamus releases CRH, which triggers the pituitary to produce ACTH from its precursor, POMC. However, the presence of cytokines in the pituitary suggested an additional layer of regulation. This study sought to understand how immune signals like LIF influence hormone production at the molecular level and whether they act independently or in concert with standard stress signals.

Methods and Experimental Design

The researchers utilized AtT20 cells, a murine cell line mimicking pituitary corticotrophs. Their methodology included:

  • Hormone Assays: Radioimmunoassays (RIA) to measure ACTH secretion and intracellular cAMP levels.
  • Signal Transduction: Immunoprecipitation and Western blotting to track the phosphorylation of STAT1 and STAT3 proteins.
  • Gene Regulation: Transfection with a luciferase reporter gene fused to the rat POMC promoter to identify specific DNA regions necessary for the LIF response.
  • Immunoneutralization: Using antibodies to block the LIF receptor and the gp130 subunit to confirm receptor-mediated effects.

Key Results: Synergy and Secretion

The most striking finding was the massive synergy between LIF and CRH. While both molecules independently stimulate ACTH secretion, their combined effect is significantly greater than the sum of their individual parts.

Figure 1: Effects of LIF, OSM, and CRH on ACTH secretion. Both LIF (a) and OSM (b) show dose-dependent stimulation of ACTH and potent synergy when combined with 20 nM CRH.

As shown in Figure 1, 1 nM of LIF caused a roughly 4-fold induction of ACTH secretion, while CRH alone caused a 6-fold induction. However, the combination of the two reached a 20-fold increase, illustrating how an immune challenge can hyper-sensitize the pituitary to brain-derived stress signals.

Parallel Signaling Pathways

Interestingly, the study revealed that LIF and CRH use different intracellular "languages." While CRH acts primarily through the cAMP pathway, LIF does not significantly increase cAMP levels. Instead, LIF activates the JAK-STAT pathway, inducing rapid phosphorylation of STAT1 and STAT3.

Figure 4: cAMP levels in AtT20 cells. While CRH significantly increases cAMP, LIF has no effect on basal levels and does not significantly enhance the CRH-induced cAMP response, suggesting parallel signaling.

This lack of convergence at the secondary messenger level (cAMP) suggests that the synergy occurs directly at the gene level, where LIF-activated STAT proteins and CRH-activated factors meet on the POMC promoter to amplify transcription.

Insights and Implications

  • Autocrine Regulation: Immunoneutralization experiments suggested that corticotrophs use LIF in an autocrine fashion to maintain basal hormone levels.
  • Glucocorticoid Feedback: Dexamethasone effectively blocked the LIF-induced response, confirming that the body's standard "off-switch" for stress remains functional even during cytokine-driven stimulation.
  • The STAT Connection: The identification of the STAT pathway as the driver for LIF action provides a clear molecular mechanism for cytokine-mediated endocrine regulation.

Limitations

While AtT20 cells are a standard model, they are tumor-derived, and dynamics may differ in primary human pituitary cells. Additionally, the study identified a 115-kD protein co-immunoprecipitating with STAT1 whose exact role remains unknown. Future work is needed to definitively map the STAT binding sites on the POMC promoter.

Reference: Ray, D. W., Ren, S. G., & Melmed, S. (1996). Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. J. Clin. Invest., 97(8), 1852–1859.

Summary updated

Abstract

We recently described the expression of leukemia inhibitory factor (LIF) in human fetal and murine corticotrophs. LIF and the related cytokine oncostatin M induced basal, and corticotropin-releasing hormone (CRH) induced proopiomelanocortin (POMC) mRNA and ACTH secretion in AtT20 cells. LIF signaling and regulation of POMC gene transcription were therefore tested. Dexamethasone inhibited both basal- and LIF-induced ACTH secretion (P<0.05) and LIF induction of ACTH was also attenuated by immuneutralization of either the LIF receptor (35%, P<0.05) or the gp130 affinity converter (41%, P<0.05). These antisera also attenuated basal ACTH secretion in the absence of added ligand (P<0.05). To examine intrapituitary LIF signaling, phosphorylation of post-receptor substrates was measured. 1 nM LIF rapidly induced tyrosyl phosphorylation of STAT 1 and STAT 3 proteins, as well as tyrosyl phosphorylation of a 115-kD protein, coimmunoprecipitated with STAT 1. The transfected rat POMC promoter -706/+64, fused to the luciferase reporter gene, was induced by LIF, which exerted strong (18-fold) synergy with CRH. Deletion of the major CRH responsive region in POMC (-323/-166) abolished CRH induction of transcription and severely limited LIF synergy. Although 8 bromo cAMP or forskolin modestly enhanced POMC transcription (2.8-fold), LIF markedly potentiated (7.4-fold) these cAMP activators. These results demonstrate that corticotroph LIF action is receptor mediated and involves activation of STAT signaling pathways. LIF potently synergizes with both CRH and cAMP induction of POMC transcription. This novel intrapituitary signaling mechanism may mediate a neuroimmune pituitary interface.
BibTeX
@article{ray1996leukemia,
  author = {David Ray and Shaolei Ren and Шломо Мелмед},
  title = {{Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.}},
  journal = {Journal of Clinical Investigation},
  year = {1996},
  doi = {10.1172/jci118615},
}
Figure